Life Sciences Real World Evidence (RWE) / Real World Data (RWD) Platforms – Review of Oracle Analytics Intelligence for Life Sciences
Tech Launch Perspective
27 Jan 2025
by
Abhishek Singh, Manu Aggarwal, Chunky Satija, Nisarg Shah
Life sciences enterprises are increasingly focusing on Real-world Evidence / Real-world Data (RWE/RWD) to promote patient centricity, identify the next opportunity, and demonstrate value for their investments. Enterprises are seeking next-generation solutions to address interoperability and data access challenges. This shift compels providers to innovate their offerings and introduce advanced solutions that enhance analytics and insights, enable interoperability, and enhance data security. Following suit, Oracle has launched its Analytics Intelligence for Life Sciences offering, which provides AI-enabled workflows, enhanced data interoperability, and pre-integrated datasets.
In this report, we examine Oracle’s current market position, key product announcements, and industry objectives. We also review Oracle’s RWE/RWD technology and cover essential RWE/RWD issues and objectives for life sciences enterprises.
Scope
Industry: life sciences
Geography: global
Segment: RWE/RWD platforms
Contents
In this report, we examine:
Key enterprise RWE/RWD issues and objectives
Oracle’s Analytics Intelligence for Life Sciences announcement
